SCHEMBL16167192

SCHEMBL16167192

Oc1ccccc1Oc1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.55
KDM4E B2RXH2 5/20 0.55
CRHBP P24387 1/20 0.55
CRHR2 Q13324 1/20 0.55
HPGD P15428 4/20 0.53
POLB P06746 3/20 0.53
APEX1 P27695 2/20 0.53
CA2 P00918 3/20 0.46
CA1 P00915 2/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
LMNA P02545 4/20 0.43
GAA P10253 4/20 0.43
JAK2 O60674 1/20 0.43
ALOX15 P16050 3/20 0.42
HSD17B10 Q99714 3/20 0.39
ALDH1A1 P00352 3/20 0.39
RAB9A P51151 2/20 0.39
CA12 O43570 2/20 0.38
CA7 P43166 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17787303 0.92 MAPT (0.52) MAPTKDM4ECRHBPCRHR2HPGD
SCHEMBL29446988 0.78 CA2 (0.62) MAPTKDM4EHPGDPOLBAPEX1
SCHEMBL18197 0.78 CA2 (0.62) MAPTKDM4EHPGDPOLBAPEX1
SCHEMBL16892543 0.77 KDM4E (0.59) MAPTKDM4ECRHBPCRHR2HPGD
SCHEMBL18921229 0.76 KDM4E (0.53) MAPTKDM4ECRHBPCRHR2HPGD
SCHEMBL8820797 0.76 CA2 (0.41) MAPTKDM4ECRHBPCRHR2HPGD
Phosphine SCHEMBL28067413 0.76 CA2 (0.59) MAPTKDM4EHPGDPOLBAPEX1
Ammonia Solution, Strong SCHEMBL28322857 0.76 CA2 (0.59) MAPTKDM4EHPGDPOLBAPEX1
SCHEMBL7806601 0.76 CA2 (0.59) MAPTKDM4EHPGDPOLBAPEX1
Methane SCHEMBL11062496 0.76 CA2 (0.59) MAPTKDM4EHPGDPOLBAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2984098-A2 DEUTERATED NUCLEOSIDE PRODRUGS USEFUL FOR TREATING HCV Achillion Pharmaceuticals, Inc. (US) 2016-02-17 EP disclosed
WO-2014169280-A2 DEUTERATED NUCLEOSIDE PRODRUGS USEFUL FOR TREATING HCV ACHILLION PHARMACEUTICALS, INC. (US) 2014-10-16 WO disclosed